Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Praxis Precision Medicines, Inc. (PRAX)
|
Add to portfolio |
|
|
|
| Price: |
$19.91
| | Metrics |
| OS: |
128.5
|
M
| |
-149
|
% ROE
|
| Market cap: |
$2.56
|
B
| |
|
|
|
Net cash:
|
$124
|
M
| |
$0.97
|
per share
|
|
EV:
|
$2.43
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($157)
|
M
| |
|
|
|
EBIT
|
($158)
|
M
| |
|
|
| EPS |
($3.05)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 216.0 | 0.0 | 0.0 | 0.0 | 18.8 |
| Revenue growth | | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 22.7 |
| Gross profit | 216.0 | 0.0 | 0.0 | 0.0 | -3.9 |
| Gross margin | 100.0% | | | | -20.7% |
| Research and development | 155.0 | 120.3 | 45.0 | 29.6 | |
| General and administrative | 59.9 | 47.1 | 17.0 | 6.2 | 3.9 |
| EBIT | -214.0 | -167.3 | -62.0 | -35.8 | -22.7 |
| EBIT margin | -99.1% | | | | -120.7% |
| Pre-tax income | -214.0 | -167.1 | -61.8 | -35.6 | -26.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.2% | |
| Net income | -214.0 | -167.1 | -70.3 | -40.7 | -26.5 |
| Net margin | -99.1% | | | | -141.0% |
| |
| Diluted EPS | ($4.64) | ($3.94) | ($7.86) | ($26.60) | ($29,223.00) |
| Shares outstanding (diluted) | 46.1 | 42.5 | 9.0 | 1.5 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|